Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis

Intensive Care Med. 2003 Jul;29(7):1205. doi: 10.1007/s00134-003-1781-4. Epub 2003 May 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Hemofiltration / methods*
  • Humans
  • Partial Thromboplastin Time
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Sepsis / drug therapy
  • Sepsis / therapy*
  • Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Protein C
  • Recombinant Proteins